文献速递MDS 与骨髓增殖性肿瘤

骨髓增生异常综合征(MDS)或疑似MDS患者骨髓穿刺细胞样本严重稀释的患病率:日本全国样本回顾性分析

Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan.
PubMed 文献 · Br J Haematol · 2024-04-08

该研究回顾性分析日本全国283例确诊或疑似MDS患者的骨髓穿刺样本,发现32.5%(92例)骨髓涂片细胞稀少(严重血液稀释),其中18.4%(52例)未见骨髓颗粒。仅20.7%(19/92)的稀释病例被主管医生识别,且医生未识别稀释时73例中50例未行骨髓活检。

要点

  • 283例可分析样本中92例(32.5%)骨髓涂片细胞稀少,52例(18.4%)未见骨髓颗粒。
  • 细胞稀少病例中仅19例(20.7%)被医生识别为血液稀释。
  • 医生未识别稀释的73例中50例未进行骨髓活检。

核心结论

  • MDS或疑似MDS患者骨髓穿刺样本严重血液稀释常见且常被医生忽视,临床医生必须认识到这一潜在关键问题。

研究设计与样本

  • 回顾性分析日本全国283例确诊或疑似MDS患者的骨髓穿刺样本。

主要发现

  • 283例中92例(32.5%)骨髓涂片细胞稀少(严重血液稀释),其中52例(18.4%)未见骨髓颗粒。
  • 92例细胞稀少病例中仅19例(20.7%)被主管医生识别为血液稀释。
  • 医生未识别稀释的73例中50例未进行骨髓活检。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bone marrow (BM) examination is a key element in the diagnosis and prognostic grading of myelodysplastic syndromes (MDSs), and obtaining adequate BM cell samples is critical for accurate test results. Massive haemodilution of aspirated BM samples is a well-known problem; however, its incidence in patients with MDS has not been well studied. We report the first study to examine the incidence of massive haemodilution in nationwide BM samples aspirated from patients diagnosed with or suspected of MDS in Japan. Among 283 cases available for analysis, BM smears from 92 cases (32.5%) were hypospicular (massively haemodiluted) and, particularly, no BM particles were observed in 52 cases (18.4%). Regarding hypospicular cases, we examined how the doctors in charge interpreted the BM smears of their patients. In only 19 of 92 cases (20.7%), doctors realised that the BM smears were haemodiluted. Furthermore, the BM biopsy, which can help diagnose hypospicular cases, was oftentimes not performed when the haemodilution was overlooked by doctors (not performed in 50 of 73 such cases). These real-world data highlight that not only researchers who are working to improve diagnostic tests but also clinicians who perform and use diagnostic tests must realise this common and potentially critical problem.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Ogata K, Mochimaru Y, Kasai N, et al. Prevalence of massively diluted bone marrow cell samples aspirated from patients with myelodysplastic syndromes (MDS) or suspected of MDS: A retrospective analysis of nationwide samples in Japan. Br J Haematol. 2024. PMID: 38590011. doi:10.1111/bjh.19447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。